|
1
|
Global Tuberculosis Report 2024, . 1st
edition. World Health Organization; Geneva: 2024
|
|
2
|
Lee H, Bea S, Kim JH, Jeong HE, Jang SH,
Son H and Shin JY: Predictors, mortality, and health outcomes of
intensive phase non-adherence to a regimen in patients with
drug-susceptible tuberculosis: A nationwide linkage database.
Public Health. 229:167–175. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Treatment of Tuberculosis, . Guidelines.
4th edition. World Health Organization; Geneva: 2010
|
|
4
|
Mereškevičienė R and Danila E: The adverse
effects of tuberculosis treatment: A comprehensive literature
review. Medicina (Kaunas). 61:9112025. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Galileya LT, Wasmann RE, Chabala C, Rabie
H, Lee J, Njahira Mukui I, Hesseling A, Zar H, Aarnoutse R, Turkova
A, et al: Evaluating pediatric tuberculosis dosing guidelines: A
model-based individual data pooled analysis. PLoS Med.
20:e10043032023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hui SYA and Lao TT: Tuberculosis in
pregnancy. Best Pract Res Clin Obstet Gynaecol. 85:34–44. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Regazzi M, Carvalho AC, Villani P and
Matteelli A: Treatment optimization in patients co-infected with
HIV and Mycobacterium tuberculosis infections: Focus on drug-drug
interactions with rifamycins. Clin Pharmacokinet. 53:489–507. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alsehali A, Alrajih H, AL-Jahdali H,
Al-Safi E, Layqah L and Baharoon S: Clinical, radiological features
and treatment outcomes of tuberculosis in patients aged 75 years
and older. J Epidemiol Glob Health. 14:1591–1601. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Salari N, Kanjoori AH, Hosseinian-Far A,
Hasheminezhad R, Mansouri K and Mohammadi M: Global prevalence of
drug-resistant tuberculosis: A systematic review and meta-analysis.
Infect Dis Poverty. 12:572023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lange C, Chesov D, Heyckendorf J, Leung
CC, Udwadia Z and Dheda K: Drug-resistant tuberculosis: An update
on disease burden, diagnosis and treatment. Respirology.
23:656–673. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akalu TY, Clements ACA, Wolde HF and Alene
KA: Economic burden of multidrug-resistant tuberculosis on patients
and households: A global systematic review and meta-analysis. Sci
Rep. 13:223612023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tanu R, Chaudhary AA, Prakash G, Yasmeen
N, Ali MAM, Raza N, Sharma PK, Kumar A, Yadav T and Kumar V:
Exploring the potential of photodynamic therapy in overcoming
multidrug resistance: Mechanisms, synergies, and clinical
advancements in infectious diseases. Front Cell Infect Microbiol.
15:16240362025. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shleeva M, Savitsky A and Kaprelyants A:
Photoinactivation of mycobacteria to combat infection diseases:
Current state and perspectives. Appl Microbiol Biotechnol.
105:4099–4109. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feese E and Ghiladi RA: Highly efficient
in vitro photodynamic inactivation of mycobacterium smegmatis. J
Antimicrob Chemother. 64:782–785. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kozobkova NV, Samtsov MP, Lugovski AP,
Bel'ko NV, Tarasov DS, Kaprelyants AS, Savitsky AP and Shleeva MO:
Photoinactivation of Mycobacterium tuberculosis and mycobacterium
smegmatis by near-infrared radiation using a trehalose-conjugated
heptamethine cyanine. Int J Mol Sci. 25:85052024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding Q, Xie Y, Xiong K, Jia H, Chen L, Li
C, Yi Q, Zhang P, Mei L and Tang BZ: From light to cure: Precision
phototherapies for antibiotic-refractory biofilm infections. Angew
Chem Int Ed Engl. 64:e2025109002025. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Youf R, Müller M, Balasini A, Thétiot F,
Müller M, Hascoët A, Jonas U, Schönherr H, Lemercier G, Montier T
and Le Gall T: Antimicrobial photodynamic therapy: Latest
developments with a focus on combinatory strategies. Pharmaceutics.
13:19952021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martins Antunes de Melo WC,
Celiešiūtė-Germanienė R, Šimonis P and Stirkė A: Antimicrobial
photodynamic therapy (aPDT) for biofilm treatments. Possible
synergy between aPDT and pulsed electric fields. Virulence.
12:2247–2272. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sung N, Back S, Jung J, Kim KH, Kim JK,
Lee JH, Ra Y, Yang HC, Lim C, Cho S, et al: Inactivation of
multidrug resistant (MDR)- and extensively drug resistant
(XDR)-Mycobacterium tuberculosis by photodynamic therapy.
Photodiagnosis Photodyn Ther. 10:694–702. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Wu A, Cheng W, Li Y, Li D, Wang L,
Zhang X and Xiao Y: Adoptive macrophage directed photodynamic
therapy of multidrug-resistant bacterial infection. Nat Commun.
14:72512023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hamblin MR: Antimicrobial photodynamic
inactivation: A bright new technique to kill resistant microbes.
Curr Opin Microbiol. 33:67–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang YY, Tanaka M, Vecchio D, Garcia-Diaz
M, Chang J, Morimoto Y and Hamblin MR: Photodynamic therapy induces
an immune response against a bacterial pathogen. Expert Rev Clin
Immunol. 8:479–494. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marfina GY, Vladimirov KB, Avetisian AO,
Starshinova AA, Kudriashov GG, Sokolovich EG and Yablonskii PK:
Bilateral cavitary multidrug- or extensively drug-resistant
tuberculosis: Role of surgery. Eur J Cardiothorac Surg. 53:618–624.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sharma R, Saxena D, Dwivedi AK and Misra
A: Inhalable microparticles containing drug combinations to target
alveolar macrophages for treatment of pulmonary tuberculosis. Pharm
Res. 18:1405–1410. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Parikh R, Patel L and Dalwadi S:
Microparticles of rifampicin: Comparison of pulmonary route with
oral route for drug uptake by alveolar macrophages, phagocytosis
activity and toxicity study in albino rats. Drug Deliv. 21:406–411.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fuchs J and Thiele J: The role of oxygen
in cutaneous photodynamic therapy. Free Radical Biol Med.
24:835–847. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sharman WM, Allen CM and van Lier JE:
Photodynamic therapeutics: Basic principles and clinical
applications. Drug Discov Today. 4:507–517. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang L, Xuan Y, Koide Y, Zhiyentayev T,
Tanaka M and Hamblin MR: Type I and type II mechanisms of
antimicrobial photodynamic therapy: An in vitro study on
gram-negative and gram-positive bacteria. Lasers Surg Med.
44:490–499. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Belton M, Brilha S, Manavaki R, Mauri F,
Nijran K, Hong YT, Patel NH, Dembek M, Tezera L, Green J, et al:
Hypoxia and tissue destruction in pulmonary TB. Thorax.
71:1145–1153. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen D, Shao J, Zhang T, Xu K, Liang C,
Cai Y, Guo Y, Chen P, Mou XZ and Dong X: Aromaticity tuning of
heavy-atom-free photosensitizers for singlet fission-enhanced
immunogenic photodynamic oncotherapy. Nano Lett. Jun 10–2024.(Epub
ahead of print).
|
|
31
|
Cui J, Zhang F, Yan D, Han T, Wang L, Wang
D and Tang BZ: ‘Trojan horse’ phototheranostics: Fine-engineering
NIR-II AIEgen camouflaged by cancer cell membrane for
homologous-targeting multimodal imaging-guided phototherapy. Adv
Mater. 35:e23026392023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lovell JF, Jin CS, Huynh E, Jin H, Kim C,
Rubinstein JL, Chan WC, Cao W, Wang LV and Zheng G: Porphysome
nanovesicles generated by porphyrin bilayers for use as multimodal
biophotonic contrast agents. Nat Mater. 10:324–332. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong J, Tang J, Li X, Zeng Y, Su X, He Y
and Liu X: Latest developments in photosensitizers: Improving
stability, specificity and responsiveness. Future Med Chem.
17:1297–1314. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shang X, Shao W, Dong W, Ren W, Du W, Li
C, Tian Y, Fang W, Liu T, Xu Q, et al: Rational engineering of
nanoplatforms with hierarchical targeting hepatic tumor and
subcellular mitochondria for enhanced image-guided photodynamic
therapy. J Nanobiotechnol. 23:6472025. View Article : Google Scholar
|
|
35
|
Tong Y, Li X, Wang D and Tang BZ:
Frontiers in photodynamic therapy: Type I NIR-II photosensitizers
with aggregation-induced emission features. Chem Commun (Camb).
62:83–97. 2026. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Correia JH, Rodrigues JA, Pimenta S, Dong
T and Yang Z: Photodynamic therapy review: Principles,
photosensitizers, applications, and future directions.
Pharmaceutics. 13:13322021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li G, Wang C, Jin B, Sun T, Sun K, Wang S
and Fan Z: Advances in smart nanotechnology-supported photodynamic
therapy for cancer. Cell Death Discov. 10:4662024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Allamyradov Y, Ben Yosef J, Annamuradov B,
Ateyeh M, Street C, Whipple H and Er AO: Photodynamic therapy
review: Past, present, future, opportunities and challenges.
Photochem. 4:434–461. 2024. View Article : Google Scholar
|
|
39
|
Peng S, Zhou X, Wang Q, Shen L, Wang ZY,
Xu H, Yang X, Redshaw C and Zhang QL: Cationic AIEgens with large
rigid π-planes: Specific bacterial imaging and treatment of
drug-resistant bacterial infections. Bioorg Chem. 159:1084122025.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li S, Peng S, Yu S, Zhi M, Su X, Zhang Q,
Redshaw C and Feng X: AIE-active photosensitizers for concomitant
fluorescence visualization and efficient photodynamic elimination
of multidrug-resistant bacteria. Dyes Pigm. 231:1123882024.
View Article : Google Scholar
|
|
41
|
Savelyeva IO, Zhdanova KA, Gradova MA,
Gradov OV and Bragina NA: Cationic porphyrins as antimicrobial and
antiviral agents in photodynamic therapy. Curr Issues Mol Biol.
45:9793–9822. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Klausen M, Ucuncu M and Bradley M: Design
of photosensitizing agents for targeted antimicrobial photodynamic
therapy. Molecules. 25:52392020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yan E, Kwek G, Qing NS, Lingesh S and Xing
B: Antimicrobial photodynamic therapy for the remote eradication of
bacteria. Chempluschem. 88:e2023000092023. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang T, Qu X, Shao J and Dong X: Organic
photosensitizers: From molecular design to phototheranostics. Chem
Soc Rev. 54:8406–8433. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu X, Huang YY, Wang Y, Wang X and Hamblin
MR: Antimicrobial photodynamic therapy to control clinically
relevant biofilm infections. Front Microbiol. 9:12992018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gonçalves RS and Braga G: Photodynamic
therapy with natural photosensitizers: Bridging oncology,
infectious diseases, and global health. Pharmaceutics. 17:15512025.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ghosh S, Ucer KB, D'Agostino R Jr, Grant
K, Sirintrapun J, Thomas MJ, Hantgan R, Bharadwaj M and Gmeiner WH:
Non-covalent assembly of meso-tetra-4-pyridyl porphine with
single-stranded DNA to form nano-sized complexes with
hydrophobicity-dependent DNA release and anti-tumor activity.
Nanomedicine. 10:451–461. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lourenço LMO, Rocha DMGC, Ramos CIV, Gomes
MC, Almeida A, Faustino MAF, Paz FAA, Neves MGPMS, Cunha  and Tomé
JPC: Photoinactivation of planktonic and biofilm forms of
Escherichia coli through the action of cationic zinc(II)
phthalocyanines. ChemPhotoChem. 3:251–260. 2019. View Article : Google Scholar
|
|
49
|
Reynoso E, Quiroga ED, Agazzi ML,
Ballatore MB, Bertolotti SG and Durantini EN: Photodynamic
inactivation of microorganisms sensitized by cationic BODIPY
derivatives potentiated by potassium iodide. Photochem Photobiol
Sci. 16:1524–1536. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang CW, Tseng SJ, Peng SF, Hwu YK and Lin
CK: Functionalized polymer spheres via one-step photoinduced
synthesis for antimicrobial activity and gene delivery.
Nanotechnology. 23:2551032012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ghorbani J, Rahban D, Aghamiri S, Teymouri
A and Bahador A: Photosensitizers in antibacterial photodynamic
therapy: An overview. Laser Ther. 27:293–302. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Imlay JA: The molecular mechanisms and
physiological consequences of oxidative stress: Lessons from a
model bacterium. Nat Rev Microbiol. 11:443–454. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Juan CA, Pérez de la Lastra JM, Plou FJ
and Pérez-Lebeña E: The chemistry of reactive oxygen species (ROS)
revisited: Outlining their role in biological macromolecules (DNA,
lipids and proteins) and induced pathologies. Int J Mol Sci.
22:46422021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li H, Fang Y and Huang J: Reactive oxygen
species mediate bioeffects of static magnetic field via impairment
of long-chain fatty acid degradation in Escherichia coli. Front
Microbiol. 16:15862332025. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Holzheimer M, Buter J and Minnaard AJ:
Chemical synthesis of cell wall constituents of Mycobacterium
tuberculosis. Chem Rev. 121:9554–9643. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Karthikeyan A, Tabassum N, Jeong GJ,
Javaid A, Mani AK, Kim TH, Kim YM, Jung WK and Khan F: Alleviation
of mycobacterial infection by impairing motility and biofilm
formation via natural and synthetic molecules. World J Microbiol
Biotechnol. 41:1132025. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shariq M, Ahmed F, Ansari O, Mursaleen A
and Sheikh JA: Phagosomal escape and sabotage: The role of ESX-1
and PDIMs in Mycobacterium tuberculosis pathogenesis. Int Rev
Immunol. 44:393–419. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chakraborti S and Sistla JC: Mycolic
acid-like lipids act as substrates for mycobacterium marinum melH.
ACS Omega. 10:41221–41232. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sahu A, Mohanty S and Mukherjee T:
Targeted photodynamic therapy for drug-resistant pulmonary
tuberculosis through mycolic acid and cyclohexadiene-aminophenyl
interactions. Curr Top Med Chem. 25:1995–1998. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Nkune NW and Abrahamse H: Possible
integration of artificial intelligence with photodynamic therapy
and diagnosis: A review. J Drug Deliv Sci Technol. 101:1062102024.
View Article : Google Scholar
|
|
61
|
Wang Y, Li T, Zhou H and Liu C:
Advancements in nanocarrier delivery systems for photodynamic
therapy in lung cancer. Int J Nanomedicine. 20:6853–6874. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang X, Qin Z, Wen Y, Chi M, Zhang L, Wu J
and Liu T: Synergistic antibacterial photodynamic therapy of
lysine-porphyrin conjugate and metal ions combination against
candida albicans and Mycobacterium tuberculosis. Front Pharmacol.
16:16261932025. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Reis MJA, Vieira C, Bartolomeu M, Faustino
MAF, Pereira AMVM, Neves MGPMS, Almeida A and Moura NMM:
A2B2-type porphyrins enhanced by N-donor
units: Synthesis optimization and photodynamic efficiency towards
S. aureus. Bioorg Chem. 162:1086072025. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Li J, Sun W, Yang Z, Gao G, Ran HH, Xu KF,
Duan QY, Liu X and Wu FG: Rational design of self-assembled
cationic porphyrin-based nanoparticles for efficient photodynamic
inactivation of bacteria. ACS Appl Mater Interfaces.
12:54378–54386. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Pogue BW, Chen B, Ochoa MI, Petusseau A,
Liu A, Gibson ALF, Maytin EV and Wilson BC: Emerging uses of
5-aminolevulinic-acid-induced protoporphyrin IX in medicine: A
review of multifaceted, ubiquitous, molecular diagnostic,
therapeutic, and theranostic opportunities. J Biomed Opt. 30 (Suppl
3):S341122025. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Bruce-Micah R, Hüttenberger D, Freitag L,
Cullum J and Foth HJ: Pharmacokinetic of ALA and h-ALA induced
porphyrins in the models mycobacterium phlei and mycobacterium
smegmatis. J Photochem Photobiol B. 97:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Dibona-Villanueva L and Fuentealba D:
Protoporphyrin IX-chitosan oligosaccharide conjugate with potent
antifungal photodynamic activity. J Agric Food Chem. 70:9276–9282.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Shi J, Lu Z, Pan Y, Sheng Y, Sun Y, Deng
L, Bradley M, Zhou L and Zhang R: Synthesis of water-soluble
protoporphyrin IX polymers and their photodynamic application. J
Appl Polym Sci. 140:e534852023. View Article : Google Scholar
|
|
69
|
Monteiro CJP, Neves MGPMS, Nativi C,
Almeida A and Faustino MAF: Porphyrin photosensitizers grafted in
cellulose supports: A review. Int J Mol Sci. 24:34752023.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Liu HY, Prentice EL and Webber MA:
Mechanisms of antimicrobial resistance in biofilms. Npj Antimicrob
Resist. 2:272024. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
He P, Jia M, Yang L, Zhang H, Chen R, Yao
W, Pan Y, Fan Q, Hu W and Huang W: Zwitterionic
photosensitizer-assembled nanocluster produces efficient
photogenerated radicals via autoionization for superior
antibacterial photodynamic therapy. Adv Mater. 37:e24189782025.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yao S, Xu F, Wang Y, Shang J, Li S, Xu X,
Liu Z, He W, Guo Z and Chen Y: Photoinduced synergism of
ferroptosis/pyroptosis/oncosis by an O2-independent
photocatalyst for enhanced tumor immunotherapy. J Am Chem Soc.
147:11132–11144. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Guo L, Pan C, Ping J, Ren P, Xu Z, Lin X,
Zhao J and Peng H: Oxygen self-enriched nanophotosensitizers based
on hollow mesoporous silica nanoparticles for enhanced photodynamic
therapy. ChemNanoMat. 11:e2025001922025. View Article : Google Scholar
|
|
74
|
Zheng Y, Wu Y, Li R, Yang R, Liu K, Zhang
Z, Liu Y and He Y: Engineering microalgae-based oxygenators for
hypoxia relief and enhanced photodynamic therapy against biofilms
in diabetic wounds healing. J Colloid Interface Sci.
702:1390072026. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Zhu Y, Gao M, Su M, Shen Y, Zhang K, Yu B
and Xu FJ: A targeting singlet oxygen battery for
multidrug-resistant bacterial deep-tissue infections. Angew Chem
Int Ed Engl. 62:e2023068032023. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Liu Z, Guo K, Yan L, Zhang K, Wang Y, Ding
X, Zhao N and Xu FJ: Janus nanoparticles targeting extracellular
polymeric substance achieve flexible elimination of drug-resistant
biofilms. Nat Commun. 14:51322023. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang H, Pan X, Liu W, Huang Y, Yi X and
Chen Z: Bacterial-mediated FRET between AIE and ACQ
photosensitizers for enhanced antimicrobial photodynamic therapy.
Chem Eng J. 486:1504322024. View Article : Google Scholar
|
|
78
|
Chen H, Li S, Wu M, Kenry Huang Z, Lee CS
and Liu B: Membrane-anchoring photosensitizer with
aggregation-induced emission characteristics for combating
multidrug-resistant bacteria. Angew Chem Int Ed Engl. 59:632–636.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Lv S, Wang C, Fu H, Xiao M, Sun Z, Tian L,
Shi L and Zhu C: Synergistic eradication of bacterial biofilms via
phage-driven EPS disruption and click-activated AIE
photosensitization. Adv Healthc Mater. 14:e02295e022952025.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
McCaffrey EF, Donato M, Keren L, Chen Z,
Delmastro A, Fitzpatrick MB, Gupta S, Greenwald NF, Baranski A,
Graf W, et al: The immunoregulatory landscape of human tuberculosis
granulomas. Nat Immunol. 23:318–329. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Agulló-Ros I, Ruedas-Torres I, Hunter L,
Bird A, Whitehead CE and Salguero FJ: Histological and
immunohistochemical characterization of granulomas in alpacas
(vicugna pacos) naturally infected with tuberculosis. Front Vet
Sci. 12:16384592025. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Duque-Correa MA, Kühl AA, Rodriguez PC,
Zedler U, Schommer-Leitner S, Rao M, Weiner J III, Hurwitz R,
Qualls JE, Kosmiadi GA, et al: Macrophage arginase-1 controls
bacterial growth and pathology in hypoxic tuberculosis granulomas.
Proc Natl Acad Sci USA. 111:E4024–E4032. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li W, You F, Yang J, Gu D, Li Y, Zhang X,
Miao L and Sun W: Antimicrobial peptide-targeted photodynamic
therapy for preventing periodontal plaque biofilm formation through
the disruption of quorum sensing system. Mater Today Bio.
33:1019702025. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Bonjorno AF, de Souza MM, Rodriguez Gini
AL, Scarim CB and Dos Santos JL: Harnessing caseinolytic proteases
ClpP1P2 for next-generation antimycobacterial agents: Mechanisms,
challenges and opportunities. Eur J Med Chem. 296:1178582025.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Campos Pacheco JE, Davids C, Yalovenko T,
Näsström E, Ahnlund M, Godaly G and Valetti S: Bioinspired
mycobacterial lipid coating of porous particles for enhanced
antimicrobial efficacy. Eur J Pharm Sci. 213:1072252025. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Li B, Wang W, Zhao L, Wu Y, Li X, Yan D,
Gao Q, Yan Y, Zhang J, Feng Y, et al: Photothermal therapy of
tuberculosis using targeting pre-activated macrophage
membrane-coated nanoparticles. Nat Nanotechnol. 19:834–845. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Yougbaré S, Mutalik C, Chung PF,
Krisnawati DI, Rinawati F, Irawan H, Kristanto H and Kuo TR: Gold
nanorod-decorated metallic MoS2 nanosheets for
synergistic photothermal and photodynamic antibacterial therapy.
Nanomaterials (Basel). 11:30642021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zou Y, Weng J, Qin Z, Zhang Y, Ji S and
Zhang H: Metal-organic framework- and graphene quantum
dot-incorporated nanofibers as dual stimuli-responsive platforms
for day/night antibacterial bio-protection. Chem Eng J.
473:1453652023. View Article : Google Scholar
|
|
89
|
Mao C, Xiang Y, Liu X, Zheng Y, Yeung KWK,
Cui Z, Yang X, Li Z, Liang Y, Zhu S and Wu S: Local
photothermal/photodynamic synergistic therapy by disrupting
bacterial membrane to accelerate reactive oxygen species permeation
and protein leakage. ACS Appl Mater Interfaces. 11:17902–17914.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Han DL, Yu PL, Liu XM, Xu YD and Wu SL:
Polydopamine modified simpleCuS@HKUST for rapid
sterilization through enhanced photothermal property and
photocatalytic ability. Rare Metals. 41:663–672. 2022. View Article : Google Scholar
|
|
91
|
Dai G, Luo Y, Liao M, Zhang P, Pan H, Yin
T, Yang Q, Zheng S, Liao J, Liu D, et al: A cytoderm metabolic
labeling AIEgen for rapid detection and intracellular ablation of
Mycobacterium tuberculosis. Cell Rep Phys Sci. 4:1012382023.
View Article : Google Scholar
|
|
92
|
Pires LHB, dos Anjos Oliveira TM, Desordi
JC, Ducas ESA, Souza LS, de Moraes EC, Borsanelli AC, Batista AA,
Gonçalves PJ and de Souza GRL: Breaking antibiotic resistance:
Porphyrin-driven photoinactivation and priming effect on
mastitis-related MDR bacteria. J Photochem Photobiol B.
271:1132462025. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Yao Y, Wu J, Song Z, Liang J and Chen J:
Advances in sonodynamic therapy of multifunctional nanomaterials
for bacterial infectious diseases. Coord Chem Rev. 548:2172102026.
View Article : Google Scholar
|
|
94
|
Hu C, Qiu Y, Guo J, Cao Y, Li D and Du Y:
An oxygen supply strategy for sonodynamic therapy in tuberculous
granuloma lesions using a catalase-loaded nanoplatform. Int J
Nanomedicine. 18:6257–6274. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Li G, Li J, Hou Y, Xie S, Xu J, Yang M, Li
D and Du Y: Levofloxacin-loaded nanosonosensitizer as a highly
efficient therapy for bacillus calmette-guérin infections based on
bacteria-specific labeling and sonotheranostic strategy. Int J
Nanomedicine. 16:6553–6573. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Xu Q, Xiu W, Li Q, Zhang Y, Li X, Ding M,
Yang D, Mou Y and Dong H: Emerging nanosonosensitizers augment
sonodynamic-mediated antimicrobial therapies. Mater Today Bio.
19:1005592023. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
He X, Hou JT, Sun X, Jangili P, An J, Qian
Y, Kim JS and Shen J: NIR-II photo-amplified sonodynamic therapy
using sodium molybdenum bronze nanoplatform against subcutaneous
Staphylococcus aureus infection. Adv Funct Mater. 32:22039642022.
View Article : Google Scholar
|
|
98
|
Kumar R, Singh P, Kolloli A, Shi L,
Bushkin Y, Tyagi S and Subbian S: Immunometabolism of phagocytes
during Mycobacterium tuberculosis infection. Front Mol Biosci.
6:1052019. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Marrocco A and Ortiz LA: Role of metabolic
reprogramming in pro-inflammatory cytokine secretion from LPS or
silica-activated macrophages. Front Immunol. 13:9361672022.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ahmad F, Rani A, Alam A, Zarin S, Pandey
S, Singh H, Hasnain SE and Ehtesham NZ: Macrophage: A cell with
many faces and functions in tuberculosis. Front Immunol.
13:7477992022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Wang L, Zhang W, Cen R, Yue C, Xiao T,
Deng Y, Li L, Sun K and Lei X: ALA-PDT regulates macrophage M1
polarization via ERK/MAPK-NLRP3 pathway to promote the early
inflammatory response. Lasers Surg Med. 54:1309–1320. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Chen X, Liu X, Li W, Zhai X, Shi X, Li W
and Hong W: Oxygen self-supplying nanocomposite with enhanced
photodynamic immunomodulatory against planktonic, biofilm and
intracellular MRSA infection. Chem Eng J. 514:1631982025.
View Article : Google Scholar
|
|
103
|
Singh S, Maurya SK, Aqdas M, Bashir H,
Arora A, Bhalla V and Agrewala JN: Mycobacterium tuberculosis
exploits MPT64 to generate myeloid-derived suppressor cells to
evade the immune system. Cell Mol Life Sci. 79:5672022. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Liu P, Liu X, Zhang L, Yan G, Zhang H, Xu
D, Wu Y, Zhang G, Wang P, Zeng Q and Wang X: ALA-PDT augments
intense inflammation in the treatment of acne vulgaris by
COX2/TREM1 mediated M1 macrophage polarization. Biochem Pharmacol.
208:1154032023. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Chen H, Wu L, Wang T, Zhang F, Song J, Fu
J, Kong X and Shi J: PTT/PDT-induced microbial apoptosis and wound
healing depend on immune activation and macrophage phenotype
transformation. Acta Biomater. 167:489–505. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Fan S, Zhao D, Wang J, Ma Y, Chen D, Huang
Y, Zhang T, Liu Y, Xia J, Huang X, et al: Photothermal and host
immune activated therapy of cutaneous tuberculosis using macrophage
targeted mesoporous polydopamine nanoparticles. Mater Today Bio.
28:1012322024. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Gail DP, Suzart VG, Du W, Kaur Sandhu A,
Jarvela J, Nantongo M, Mwebaza I, Panigrahi S, Freeman ML, Canaday
DH, et al: Mycobacterium tuberculosis impairs human memory
CD4+ T cell recognition of M2 but not M1-like
macrophages. iScience. 26:1077062023. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Li J, Wang Y, He L, Yang L, Tao T, Bai L
and Luo Y: Host-directed therapeutic targets in macrophages and
their ligands against mycobacteria tuberculosis. Infect Immun.
93:e00063252025. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Krishna Prasad GVR, Grigsby SJ, Erkenswick
GA, Portal-Celhay C, Mittal E, Yang G, Fallon SM, Chen F, Klevorn
T, Jain N, et al: Macrophage-T cell interactions promote SLAMF1
expression for enhanced TB defense. Nat Commun. 16:67942025.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Li Y, Du S, Feng Y, Zhou X, Zhao K, Wang
J, Zhou Q, Shi Y, Younas A, Shen Y and Wang S: Nitric
oxide-enhanced chitosan-based nanoparticles for dual-mode
photothermal and photodynamic therapy in infected wounds. Adv
Healthc Mater. 15:e025842026. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Kong X, Yang J, Wang J, Li J, Jin X, Cai
J, Ruan Y, Chen R, Shen L and Pi J: Advancing roles of nitric oxide
in tuberculosis: Promising targets for novel anti-TB therapeutics.
Microbiol Res. 300:1282922025. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Nikonov SD, Bredikhin DA, Belogorodtsev SN
and Schwartz YS: Photodynamic inactivation of Mycobacterium
tuberculosis using alluminium phthalocyanine. Bull Exp Biol Med.
175:367–370. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
O'Riordan K, Sharlin DS, Gross J, Chang S,
Errabelli D, Akilov OE, Kosaka S, Nau GJ and Hasan T:
Photoinactivation of mycobacteria in vitro and in a new murine
model of localized mycobacterium bovis BCG-induced granulomatous
infection. Antimicrob Agents Chemother. 50:1828–1834. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Moloudi K, Abrahamse H and George BP:
Photodynamic therapy-induced inflammation and adverse effects: An
updated review. Biomed J. Jul 15–2025.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Ibbotson SH, Wong TH, Morton CA, Collier
NJ, Haylett A, McKenna KE, Mallipeddi R, Moseley H, Rhodes LE,
Seukeran DC, et al: Adverse effects of topical photodynamic
therapy: A consensus review and approach to management. Br J
Dermatol. 180:715–729. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Matthews W, Rizzoni W, Mitchell J, Russo A
and Pass H: In vitro photodynamic therapy of human lung cancer. J
Surg Res. 47:276–281. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Shafirstein G, Bellnier DA, Oakley E,
Hamilton S, Habitzruther M, Tworek L, Hutson A, Spernyak JA, Sexton
S, Curtin L, et al: Irradiance controls photodynamic efficacy and
tissue heating in experimental tumours: Implication for
interstitial PDT of locally advanced cancer. Br J Cancer.
119:1191–1199. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Lin S, Zhang Q, Liu J, Lin B, Zhao D, Yang
J, Fang J, Xu JF, Pi J and Yang F: Advancements in photodynamic
therapy for tuberculosis treatment. Microb Pathog. 210:1082072026.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Shimojo Y, Morizane Y, Sonokawa T, Usuda J
and Nishimura T: Optical characteristics of human lung cancer for
photodynamic therapy with measured absorption and reduced
scattering coefficients. J Biomed Opt. 30:0480012025. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Declercq A, Güvenç C and De Haes P:
Proposition of standardized protocol for photodynamic therapy for
vulvar lichen sclerosus. J Dermatolog Treat. 33:560–568. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Zhao Y, Zhang X, Xu Y, Chen Z, Hwang B,
Kim H, Liu H, Li X and Yoon J: A renal clearable nano-assembly with
förster resonance energy transfer amplified superoxide radical and
heat generation to overcome hypoxia resistance in
phototherapeutics. Angew Chem Int Ed Engl. 63:e2024115142024.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Khan S, Song B, Saad MA, Boodhoo D, Farias
S, Trzcinski JM, Li S, Lilge LD, Pogue BW, Liang R, et al: Enabling
point of care optical diagnostics and treatment of oral lesions in
resource-limited settings: Preclinical development and evaluation
of a low-cost theranostic intraoral device for image-guided
photodynamic therapy. Biophotonics Discov. 2:0423052025.
|
|
123
|
Wang H, Li B, Sun Y, Ma Q, Feng Y, Jia Y,
Wang W, Su M, Liu X, Shu B, et al: NIR-II AIE luminogen-based
erythrocyte-like nanoparticles with granuloma-targeting and
self-oxygenation characteristics for combined phototherapy of
tuberculosis. Adv Mater. 36:e24061432024. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Yan D, Li X, Wang H, Li B, Wang W, Liao Y,
Tang BZ and Wang D: NIR-II aggregation-induced emission
nanoparticles camouflaged with preactivated macrophage membranes
for phototheranostics of pulmonary tuberculosis. Nat Protoc.
20:2560–2585. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Chang JE, Oak CH, Sung N and Jheon S: The
potential application of photodynamic therapy in drug-resistant
tuberculosis. J Photochem Photobiol B. 150:60–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Gopalaswamy R and Subbian S: The power of
resistance: Mechanisms of antimicrobial resistance in Mycobacterium
tuberculosis and its impact on tuberculosis management. Clin
Microbiol Rev. 39:e00194252026. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Burgess A and MacGowan A: Antibiotic
resistance. Medicine. 54:40–46. 2026. View Article : Google Scholar
|
